Clinical trial
An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
NCT02436239 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 2, 2015
- Completion date
- July 23, 2018
- Enrollment
- 330 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.